phylomers for traumatic brain injury/stroke(Phylogica)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Namephylomers for traumatic brain injury/stroke(Phylogica)
Drug Alias NameJun N terminal kinase inhibitors (Phylogica)S-22 (Phylogica)PYC-98S-20S-35 +[14] 
ClassificationBiologics > Protein drugs > Recombinant polypeptideNatural product/Extract
Mechanisms of ActionApoptosis inhibitorsNeuroprotectantsc-Jun N-terminal kinase inhibitors
Targetsc-Jun N-terminal kinase
Therapy Area/IndicationsStrokeBrain Injuries
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPYC Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPYC Therapeutics LLC
Active IndicationsN/A
Inactive IndicationsStrokeBrain Injuries

Other Information

ATC CodeN/A
Related LinksN/A